Moneycontrol
    Moneycontrol PRO

    Unjha Formulations

    Jump to

    • Unjha Formula Standalone December 2025 Net Sales at Rs 4.41 crore, up 17.15% Y-o-Y

    • Syncom Formula Consolidated September 2025 Net Sales at Rs 121.72 crore, up 18.96% Y-o-Y

    • Syncom Formula Standalone September 2025 Net Sales at Rs 121.44 crore, up 19.65% Y-o-Y

    • Unjha Formula Standalone September 2025 Net Sales at Rs 4.29 crore, up 13.31% Y-o-Y

    • Syncom Formula Standalone June 2025 Net Sales at Rs 116.55 crore, up 34.22% Y-o-Y

    • Unjha Formula Standalone June 2025 Net Sales at Rs 3.63 crore, down 8.05% Y-o-Y

    • Syncom Formula Consolidated March 2025 Net Sales at Rs 148.88 crore, up 99.64% Y-o-Y

    • Syncom Formula Standalone March 2025 Net Sales at Rs 148.46 crore, up 102.64% Y-o-Y

    • Unjha Formula Standalone March 2025 Net Sales at Rs 2.37 crore, down 46.57% Y-o-Y

    • Syncom Formula Consolidated December 2024 Net Sales at Rs 127.53 crore, up 95.78% Y-o-Y

    • Syncom Formula Standalone December 2024 Net Sales at Rs 127.03 crore, up 100.54% Y-o-Y

    • Unjha Formula Standalone December 2024 Net Sales at Rs 3.76 crore, down 32.15% Y-o-Y

    • Bajaj Healthcare bags major approval from DCGI to make API, formulation of antipsychotic drug Pimavanserin

      Bajaj Health has also extended the offer for Pimavanserin to several leading pharma companies to ensure availability in Indian market. The company said it has a 'strong manufacturing expertise' which it aims to leverage.

    • Dangers of Vitamin D overdose: Kidney stones, nausea, vomiting, other health risks

      Vitamin D is essential for various bodily functions. However, it’s important to follow the recommended daily limits to avoid risks of overdose. Always consult your doctor before taking vitamin D supplements, especially if you're unsure about your vitamin D levels.

    • Syncom Formula Consolidated September 2024 Net Sales at Rs 102.31 crore, up 60.27% Y-o-Y

    • Syncom Formula Standalone September 2024 Net Sales at Rs 101.49 crore, up 62.68% Y-o-Y

    • Stock Radar: Bajaj Finance, Aarti Drugs, Shilpa Medicare, CESC, Ola Electric, Diffusion Engineers in focus on Friday

      Bank of Baroda, Mahindra & Mahindra Financial Services, Avenue Supermarts, Cyient DLM, Refex Industries, Sundaram-Clayton, Reliance Power, Canara Bank, and Unicommerce eSolutions will be in focus on October 4.

    • Dermal fillers vs facelifts: Know the difference between the two popular choices

      Understanding the world of cosmetic procedures can be daunting, especially with the array of myths and facts surrounding fillers and facelifts. It is vital to know your options and consult with a qualified professional to empower yourself and make informed decisions that align with your aesthetic goals and personal needs.

    • Best ways to boost your vitamin D naturally: Sunlight, foods, and supplements

      Foods high in vitamin D: It is essential for bone health, immune support, and overall well-being, yet many people in India suffer from a deficiency. Foods rich in Vitamin D, such as fatty fish, egg yolks, fortified products, and mushrooms, can help.

    • Syncom Formula Consolidated June 2024 Net Sales at Rs 87.26 crore, up 45.82% Y-o-Y

    • Syncom Formula Standalone June 2024 Net Sales at Rs 86.83 crore, up 46.27% Y-o-Y

    • Unjha Formula Standalone June 2024 Net Sales at Rs 3.95 crore, up 5.12% Y-o-Y

    • Syncom Formula Standalone March 2024 Net Sales at Rs 73.27 crore, up 19.39% Y-o-Y

    • Syncom Formula Consolidated March 2024 Net Sales at Rs 74.57 crore, up 22.29% Y-o-Y

    • Unjha Formula Standalone March 2024 Net Sales at Rs 4.43 crore, up 56.09% Y-o-Y

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347